glp 1 agonisté GLP-1 Receptor Agonist Market Growth Analysis La molécule du mois :

Studies have shown that GLP-1R agonists not only promote insulin secretion and exert glucose-lowering effects but also effectively delay gastric emptying, reduce intestinal motility, activate neural pathways in the hypothalamus and appetite regulation areas, resulting in decreased appetite and reduced food intake, thus treating obesity

Back Underwerth, D (June 2017) 'How does obesity cause cancer?', MD Anderson Center

Exenatide ameliorates intramyocellular lipid deposition through improving insulin sensitivity and activating the AMP-activated protein kinase (AMPK) signaling pathway without BW reduction [18]

Bollag RJ, Zhong Q, Phillips P et al (2000) Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors

Here are the key results from landmark trials that established its clinical credibility